Clinical Trials
4
Active:4
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
7
CIMA_AEMPS:5
NMPA:2
Drug Approvals
Esculin and Digitalisglycosides Eye Drops
- Product Name
- 施图伦
- Approval Number
- 国药准字HJ20130295
- Approval Date
- Jun 27, 2024
NMPA
Esculin and Digitalisglycosides Eye Drops
- Product Name
- 施图伦
- Approval Number
- H20130295
- Approval Date
- Nov 15, 2019
NMPA
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)No trials found
News
No news found